Clinical trial · Observational
Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors
NCT05631002CI-TRIAL-00062401unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Fat composition of the spinal tumors is positively correlated with classification and differential diagnosis of benign and malignant tumors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bone Tumor | Bone Neoplasm | ALIAS | 0.90 |
| Spinal Tumor | Spinal Cord Neoplasm | PROBABILISTIC | 0.70 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chemical shift encoding-based water-fat MRI | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Patients with benign spinal tumor
- interventionNames
- Diagnostic Test: Chemical shift encoding-based water-fat MRI
- label
- Patients with intermediate spinal tumor
- interventionNames
- Diagnostic Test: Chemical shift encoding-based water-fat MRI
- label
- Patients with malignant spinal tumor
- interventionNames
- Diagnostic Test: Chemical shift encoding-based water-fat MRI
Primary outcomes (1)
- measure
- Type of tumor
- timeFrame
- One month before treatment
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Pathological biopsy of a patient with diagnosed spinal tumor lesion, and preoperative examination Chemical shift encoding-based water-fat MRI was performed. Exclusion Criteria: * Recurrent neoplasms; Lesion diameter \< 1 cm; Poor image quality.
References
Publications (0)
Data not yet available
No reference posted for this study.